Molecular cytogenetics field is witnessing a significant growth owing to the growing demand of FISH and aCGH techniques. The advent of FISH has managed to overcome the loopholes of conventional cytogenetics techniques; FISH enables the detection of both structural and numerical chromosomal rearrangements. The technique has been used significantly over the past few years for the detection of copy number variations and assessment of specific nucleic acids.
The research report on the molecular cytogenetics market provides detailed analysis of the global market and helps in understanding the driving forces for the growth of these technologies. The overall molecular cytogenetics market is categorized on the basis of technology in two major categories, namely, Fluorescent In-situ hybridization (FISH) and array based comparative genomic hybridization (aCGH). The market is also categorized on the basis of applications in which major areas such as genetic disorders, cancer, personalized medicine and others are covered. The market for all these segments is estimated for the period 2011 – 2019 in terms of value (USD Million).
The market has also been segmented geographically into four regions namely North America, Europe, Asia-Pacific, and Rest of the World (RoW). Market size and forecast has been provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the molecular cytogenetics market and future opportunities are provided in the report.
Competitive landscape and end user analysis for the product types is highlighted and the market players are profiled with attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of the key players for 2012 are provided, and recommendations to accentuate market shares and ensure sustainability are also put forward in this report. Key market player profiles in this report include Abbott Laboratories, Affymetrix, Inc., Agilent Technologies, Inc., Applied Spectral Imaging, Life Technologies Corporation, Leica Biosystems, Illumina, inc., Oxford Gene Technology and others.
The global molecular cytogenetics market is segmented into the following categories:
Molecular Cytogenetics Market, by Technology
Molecular Cytogenetics Market, by Applications
- Personalized Medicines
- Genetic Disorders
Molecular Cytogenetics Market, by Geography
- North America